Meet Samuel – Your Personal Investing Prophet
- Start a conversation with TipRanks’ trusted, data-backed investment intelligence
- Ask Samuel about stocks, your portfolio, or the market and get instant, personalized insights in seconds
PainReform ( (PRFX) ) has shared an announcement.
On May 7, 2026, PRF Technologies Ltd. entered into a Standby Equity Purchase Agreement with Yorkville affiliate YA II PN, LTD., giving the company the right, but not the obligation, to sell up to $10 million of its ordinary shares over 36 months. The shares will be sold through discretionary “Advances” at a price set at 97% of the lowest volume-weighted average price over a three-day period, subject to ownership, registration, and pricing limitations designed to cap Yorkville’s holding at below 9.99% of outstanding voting power.
As part of the arrangement, PRF Technologies paid Yorkville a 1% commitment fee in four installments, with the first tranche and a $25,000 structuring fee settled on May 7, 2026 in the form of 12,192 ordinary shares each, and the remaining commitment fee installments payable in cash every three months. The agreement provides PRF Technologies with flexible access to equity capital that can support future financing needs while potentially diluting existing shareholders over time, and its use is conditioned on maintaining an effective SEC registration statement covering both the commitment and future advance shares.
Spark’s Take on PRFX Stock
According to Spark, TipRanks’ AI Analyst, PRFX is a Neutral.
The score is driven down primarily by very weak financial performance (minimal revenue, large ongoing losses, and continued cash burn). Technicals also remain unfavorable with a clear downtrend and negative momentum, despite oversold readings. Valuation provides limited support because the company is loss-making (negative P/E) and no dividend yield is available.
To see Spark’s full report on PRFX stock, click here.
More about PainReform
PRF Technologies Ltd., listed on the Nasdaq Capital Market under the ticker PRFX, is an Israel-based company that issues ordinary shares with no par value and operates as a foreign private issuer in the U.S. capital markets. The company relies on home country practice exemptions under Nasdaq rules, allowing it to structure equity financings without seeking shareholder approval otherwise required in the U.S.
Average Trading Volume: 722,315
Technical Sentiment Signal: Strong Sell
Current Market Cap: $1.61M
Learn more about PRFX stock on TipRanks’ Stock Analysis page.